Cargando…
Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease
Gut microbiota has been demonstrated to have a significant impact on the initiation, progression and development of complications associated with multiple liver diseases. Notably, nonalcoholic fatty liver diseases, including nonalcoholic steatohepatitis and cirrhosis, severe alcoholic hepatitis, pri...
Autores principales: | Philips, Cyriac Abby, Augustine, Philip, Yerol, Praveen Kumar, Ramesh, Ganesh Narayan, Ahamed, Rizwan, Rajesh, Sasidharan, George, Tom, Kumbar, Sandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132020/ https://www.ncbi.nlm.nih.gov/pubmed/32274349 http://dx.doi.org/10.14218/JCTH.2019.00035 |
Ejemplares similares
-
Outcomes and Toxicology of Herbal Drugs in Alcoholic Hepatitis – A Single Center Experience from India
por: Philips, Cyriac Abby, et al.
Publicado: (2019) -
Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care
por: Philips, Cyriac Abby, et al.
Publicado: (2021) -
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020) -
One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease
por: Philips, Cyriac Abby, et al.
Publicado: (2020) -
Severe alcoholic hepatitis: current perspectives
por: Philips, Cyriac Abby, et al.
Publicado: (2019)